Ulinastatin Improves Endothelial Cells Injury, Attenuating Cardiac Ischemia/Reperfusion Injury via Suppressing Tissue kallikrein-kinin System Activation
Cited by 0
Related Papers
Hyperglycemia is a strong predictor of poor prognosis in COVID-19
|Diabetes Research and Clinical Practice|2020|89
Ulinastatin attenuated cardiac ischaemia/reperfusion injury by suppressing activation of the tissue kallikrein‐kinin system
|British Journal of Pharmacology|2024|7